- Home
- OFLX vs ATYR Comparison
OFLX vs ATYR Comparison
Compare OFLX & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFLX
- ATYR
- Stock Information
- Founded
- OFLX 1975
- ATYR 2005
- Country
- OFLX United States
- ATYR United States
- Employees
- OFLX N/A
- ATYR N/A
- Industry
- OFLX Industrial Specialties
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OFLX Industrials
- ATYR Health Care
- Exchange
- OFLX Nasdaq
- ATYR Nasdaq
- Market Cap
- OFLX 344.9M
- ATYR 306.2M
- IPO Year
- OFLX 2005
- ATYR 2015
- Fundamental
- Price
- OFLX $32.32
- ATYR $5.22
- Analyst Decision
- OFLX
- ATYR Strong Buy
- Analyst Count
- OFLX 0
- ATYR 6
- Target Price
- OFLX N/A
- ATYR $20.20
- AVG Volume (30 Days)
- OFLX 44.0K
- ATYR 2.5M
- Earning Date
- OFLX 07-30-2025
- ATYR 08-12-2025
- Dividend Yield
- OFLX 4.21%
- ATYR N/A
- EPS Growth
- OFLX N/A
- ATYR N/A
- EPS
- OFLX 1.72
- ATYR N/A
- Revenue
- OFLX $99,795,000.00
- ATYR N/A
- Revenue This Year
- OFLX N/A
- ATYR $960.85
- Revenue Next Year
- OFLX N/A
- ATYR $1,283.47
- P/E Ratio
- OFLX $18.82
- ATYR N/A
- Revenue Growth
- OFLX N/A
- ATYR N/A
- 52 Week Low
- OFLX $28.12
- ATYR $1.42
- 52 Week High
- OFLX $57.81
- ATYR $5.98
- Technical
- Relative Strength Index (RSI)
- OFLX 53.10
- ATYR 62.87
- Support Level
- OFLX $32.00
- ATYR $5.02
- Resistance Level
- OFLX $34.35
- ATYR $5.98
- Average True Range (ATR)
- OFLX 1.45
- ATYR 0.45
- MACD
- OFLX 0.09
- ATYR -0.04
- Stochastic Oscillator
- OFLX 57.62
- ATYR 52.94
About OFLX Omega Flex Inc.
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.